These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 1684245)
1. Role of sympathomimetic amines during cardiopulmonary resuscitation. Waller DG; Robertson CE Resuscitation; 1991 Oct; 22(2):181-90. PubMed ID: 1684245 [No Abstract] [Full Text] [Related]
2. Vasopressor agents for cardiopulmonary resuscitation. Cao L; Weil MH; Sun S; Tang W J Cardiovasc Pharmacol Ther; 2003 Jun; 8(2):115-21. PubMed ID: 12808484 [TBL] [Abstract][Full Text] [Related]
3. Epinephrine for resuscitation from cardiac arrest: A double-edged sword? Sutton RM; Berg RA; Helfaer MA Crit Care Med; 2009 Apr; 37(4):1518-20. PubMed ID: 19318848 [No Abstract] [Full Text] [Related]
4. Adrenergic agonist drug administration during cardiopulmonary resuscitation. Lindner KH Crit Care Med; 1993 Sep; 21(9 Suppl):S324-5. PubMed ID: 8103444 [No Abstract] [Full Text] [Related]
5. Levosimendan improves the initial outcome of cardiopulmonary resuscitation in a swine model of cardiac arrest. Koudouna E; Xanthos T; Bassiakou E; Goulas S; Lelovas P; Papadimitriou D; Tsirikos N; Papadimitriou L Acta Anaesthesiol Scand; 2007 Sep; 51(8):1123-9. PubMed ID: 17697310 [TBL] [Abstract][Full Text] [Related]
6. Catecholamines in cardiac arrest: role of alpha agonists, beta-adrenergic blockers and high-dose epinephrine. Hilwig RW; Kern KB; Berg RA; Sanders AB; Otto CW; Ewy GA Resuscitation; 2000 Oct; 47(2):203-8. PubMed ID: 11008160 [No Abstract] [Full Text] [Related]
7. Adrenaline for the pharmacological treatment of cardiac arrest... going, going, gone? McQueen C; Gates S; Perkins GD Resuscitation; 2012 Aug; 83(8):921-2. PubMed ID: 22794111 [No Abstract] [Full Text] [Related]
8. Determinants of survival after rodent cardiac arrest: implications for therapy with adrenergic agents. von Planta I; Wagner O; von Planta M; Ritz R Int J Cardiol; 1993 Mar; 38(3):235-45. PubMed ID: 8096498 [TBL] [Abstract][Full Text] [Related]
10. First Report of Survival in Refractory Ventricular Fibrillation After Dual-Axis Defibrillation and Esmolol Administration. Boehm KM; Keyes DC; Mader LE; Moccia JM West J Emerg Med; 2016 Nov; 17(6):762-765. PubMed ID: 27833686 [TBL] [Abstract][Full Text] [Related]
11. Epinephrine increases the severity of postresuscitation myocardial dysfunction. Tang W; Weil MH; Sun S; Noc M; Yang L; Gazmuri RJ Circulation; 1995 Nov; 92(10):3089-93. PubMed ID: 7586280 [TBL] [Abstract][Full Text] [Related]
12. Descriptive Analysis of Medication Administration During Inpatient Cardiopulmonary Arrest Resuscitation (from the Mayo Registry for Telemetry Efficacy in Arrest Study). Snipelisky D; Ray J; Matcha G; Roy A; Dumitrascu A; Harris D; Bosworth V; Clark B; Thomas CS; Heckman MG; Vadeboncoeur T; Kusumoto F; Burton MC Am J Cardiol; 2016 May; 117(10):1610-1615. PubMed ID: 27015887 [TBL] [Abstract][Full Text] [Related]
19. Pediatric Pulseless Arrest With "Nonshockable" Rhythm: Does Faster Time to Epinephrine Improve Outcome? Tasker RC; Randolph AG JAMA; 2015 Aug; 314(8):776-7. PubMed ID: 26305646 [No Abstract] [Full Text] [Related]
20. Evidence favoring the use of an alpha2-selective vasopressor agent for cardiopulmonary resuscitation. Pellis T; Weil MH; Tang W; Sun S; Xie J; Song L; Checchia P Circulation; 2003 Nov; 108(21):2716-21. PubMed ID: 14623815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]